BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31486756)

  • 1. Mitochondrial and Oxidative Impacts of Short and Long-term Administration of HAART on HIV Patients.
    Ikekpeazu JE; Orji OC; Uchendu IK; Ezeanyika LUS
    Curr Clin Pharmacol; 2020; 15(2):110-124. PubMed ID: 31486756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Peroxidation and Altered Antioxidant Profiles with Pediatric HIV Infection and Antiretroviral Therapy in Addis Ababa, Ethiopia.
    Mebrat Y; Amogne W; Mekasha A; Gleason RL; Seifu D
    J Trop Pediatr; 2017 Jun; 63(3):196-202. PubMed ID: 27940963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.
    Abe OE; Fagbule OF; Olaniyi OO; Adisa AO; Gbolahan OO
    Pan Afr Med J; 2021; 38():370. PubMed ID: 34367449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients.
    Awodele O; Olayemi SO; Nwite JA; Adeyemo TA
    J Infect Dev Ctries; 2012 Jan; 6(1):79-85. PubMed ID: 22240433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
    Sundaram M; Saghayam S; Priya B; Venkatesh KK; Balakrishnan P; Shankar EM; Murugavel KG; Solomon S; Kumarasamy N
    Int J Infect Dis; 2008 Nov; 12(6):e61-6. PubMed ID: 18621564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
    Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence and Pattern of Thyroid Dysfunction in HAART-Naïve HIV Patients in Enugu, Nigeria: A Cross-Sectional Comparative Study.
    Ugwueze CV; Young EE; Unachukwu CN; Onyenekwe BM; Nwatu CB; Okafor CI; Ezeude CM; Ezeokpo BC
    West Afr J Med; 2021 Dec; 38(12):1200-1205. PubMed ID: 35037450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria.
    Ekun OA; Fasela EO; Oladele DA; Liboro GO; Raheem TY
    Pan Afr Med J; 2021; 38():206. PubMed ID: 33995812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and risk factors for distal sensory polyneuropathy in HIV infection in a developing country.
    Ekenze OS; Nwosu CM; Ogunniyi A
    Int J STD AIDS; 2014 Mar; 25(3):178-83. PubMed ID: 23970649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
    Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
    Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients.
    Clerici M; Seminari E; Maggiolo F; Pan A; Migliorino M; Trabattoni D; Castelli F; Suter F; Fusi ML; Minoli L; Carosi G; Maserati R;
    AIDS; 2002 Sep; 16(13):1767-73. PubMed ID: 12218388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.
    Mussini C; Pinti M; Bugarini R; Borghi V; Nasi M; Nemes E; Troiano L; Guaraldi G; Bedini A; Sabin C; Esposito R; Cossarizza A
    AIDS; 2005 Oct; 19(15):1627-33. PubMed ID: 16184032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia?
    Lopez O; Bonnefont-Rousselot D; Edeas M; Emerit J; Bricaire F
    Biomed Pharmacother; 2003; 57(3-4):113-6. PubMed ID: 12818471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria.
    Sulaiman MM; Shettima J; Ummate I; Arogundade FA; Yusuph H; Nwankwo E; Sanusi AA; Akinsola A
    Saudi J Kidney Dis Transpl; 2022; 33(1):72-79. PubMed ID: 36647981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients.
    Chiappini F; Teicher E; Saffroy R; Pham P; Falissard B; Barrier A; Chevalier S; Debuire B; Vittecoq D; Lemoine A
    Lab Invest; 2004 Jul; 84(7):908-14. PubMed ID: 15122308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
    Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
    Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid profile in HIV/AIDS patients in Nigeria.
    Adewole OO; Eze S; Betiku Y; Anteyi E; Wada I; Ajuwon Z; Erhabor G
    Afr Health Sci; 2010 Jun; 10(2):144-9. PubMed ID: 21326966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between antiretroviral therapy and oxidative stress in HIV seropositive patients.
    Popoola TD; Awodele O
    Afr J Med Med Sci; 2016 May; 45(1):5-21. PubMed ID: 28686824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.